Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Korea Infants

NCT04381689 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

245

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: IL-YANG FLU Vaccine Prefilled Syringe INJ.
BIOLOGICAL: Fluarix Tetra Pre-filled Syringe

Sponsor

Il-Yang Pharm. Co., Ltd.